GVCAX
Price
$10.39
Change
+$0.01 (+0.10%)
Updated
May 8 closing price
Net Assets
207.03M
VMVIX
Price
$62.58
Change
+$0.46 (+0.74%)
Updated
May 8 closing price
Net Assets
29.07B
Ad is loading...

GVCAX vs VMVIX

Header iconGVCAX vs VMVIX Comparison
Open Charts GVCAX vs VMVIXBanner chart's image
Gabelli Value 25 AAA
Price$10.39
Change+$0.01 (+0.10%)
VolumeN/A
Net Assets207.03M
Vanguard Mid-Cap Value Index Investor
Price$62.58
Change+$0.46 (+0.74%)
VolumeN/A
Net Assets29.07B
GVCAX vs VMVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GVCAX vs. VMVIX commentary
May 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GVCAX is a Buy and VMVIX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
VMVIX has more cash in the bank: 29.1B vs. GVCAX (207M). VMVIX pays higher dividends than GVCAX: VMVIX (2.27) vs GVCAX (0.53). GVCAX was incepted earlier than VMVIX: GVCAX (15 years) vs VMVIX (19 years). GVCAX (1.49) is less costly to investors than VMVIX (0.19). VMVIX is a more actively managed with annual turnover of: 19.00 vs. GVCAX (5.00). GVCAX has a lower initial minimum investment than VMVIX: GVCAX (1000) vs VMVIX (3000). GVCAX annual gain was more profitable for investors over the last year : 5.11 vs. VMVIX (3.71). VMVIX return over 5 years is better than : 75.04 vs. GVCAX (-4.06).
GVCAXVMVIXGVCAX / VMVIX
Total Expense Ratio1.490.19784%
Annual Report Gross Expense Ratio1.490.19784%
Fund Existence15 years19 years-
Gain YTD5.274-2.409-219%
Front LoadN/AN/A-
Min. Initial Investment1000300033%
Min. Initial Investment IRAN/AN/A-
Net Assets207M29.1B1%
Annual Yield % from dividends0.532.2724%
Returns for 1 year5.113.71138%
Returns for 3 years-11.2214.10-80%
Returns for 5 years-4.0675.04-5%
Returns for 10 years-42.3973.59-58%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BBDO2.400.30
+14.29%
Banco Bradesco SA
GLUE4.220.37
+9.61%
Monte Rosa Therapeutics
GRC37.751.07
+2.92%
Gorman-Rupp Company (The)
SNDR23.030.63
+2.81%
Schneider National
KALA3.43-0.02
-0.58%
Kala BIO